Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice.
Zhang, Xiaobing; Song, Yunfei; Ding, Yipei; Wang, Wei; Liao, Ling; Zhong, Jin; Sun, Pengbo; Lei, Fan; Zhang, Yaou; Xie, Weidong.
; 23(8)2018 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-30060618
The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease.
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study.
Role of Hedgehog Signaling Pathway in NASH.
Microbiota, Obesity and NAFLD.
Le microbiote et les stéatopathies métaboliques.
[NON-ALCOHOLIC FATTY LIVER DISEASE].
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1ß.
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.